摘要
Retraction Note to: Cell Death and Diseasehttps://doi.org/10.1038/cddis.2017.46, published online 16 March 2017 The Editors-in-Chief have retracted this article. Image integrity concerns were found within figure 1, between figures 1 and 2, between figures 2 and 3, and between figures 3 and 4. The images provided by the authors were not sufficient to resolve the concerns. The Editors have lost confidence in the data which supports the conclusions of the article. Authors Juan Li and Peijun Liu disagree with this retraction. All other authors have not responded to the publisher regarding this retraction.
| 源语言 | 英语 |
|---|---|
| 文章编号 | 860 |
| 期刊 | Cell Death and Disease |
| 卷 | 16 |
| 期 | 1 |
| DOI |
|
| 出版状态 | 已出版 - 12月 2025 |
| 已对外发布 | 是 |
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
-
可持续发展目标 3 良好健康与福祉
学术指纹
探究 'Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)' 的科研主题。它们共同构成独一无二的指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver